Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.
Expert: Digital Transformation is Key Part of Biopharma C-Suite Goals for 2024
Stephanie L. Woerner, PhD, director and principal research scientist at the MIT Center for Information Systems Research, discusses the outlook for next year among biopharma firms.
Why Data Should Be a Top Priority
MIT’s Barbara Wixom, PhD, outlines the importance of data-powered research in producing financial success.
Leveraging Data for Informed Decision Making
In this latest Harvard Business School Healthcare Alumni Association Q&A, Ayelet Israeli, PhD, explains the potential—as well as limitations—of these offerings and pragmatic guardrails for deployment in organizations.
Embracing the 60-Plus Economy
In this latest Harvard Business School Healthcare Alumni Association Q&A, Susan Wilner Golden, DSc, lecturer at the Stanford Graduate School of Business, reveals an untapped $22 trillion global opportunity for all companies and others supporting healthy aging and longer life spans.
Traversing the Biopharma Career Landscape
In this latest Harvard Business School Healthcare Alumni Association Q&A, Dr. Peter Cappelli, Professor of Management at The Wharton School and Director of Wharton’s Center for Human Resources, explains how biopharma C-suites can lead their teams through 2023’s turbulent times.
Navigating One’s Bio-Pharma Career through 2023’s Turbulent Job Markets
Jasmin Patel of a-Connect provides insight on how to navigate the ebbs and flows of employment.
Creating Scalable Solutions in a Cost-conscious Healthcare Ecosystem
Dr. Liz Kwo of Everly Health outlines 2023 predictions for AI, including how it can be beneficial to patients
Driving ESG through 2023’s Economic Headwinds
A Q&A with AstraZeneca’s Country President for Belgium & Luxembourg, Keira Driansky
Investing in Success
Dr. Troy Sarich of Janssen reveals the company's approach to tackling financial challenges as they pertain to tech
Disrupting the Pharmaceutical Industry
A Harvard Business School Healthcare Alumni Association C-suite Q&A with Mark Cuban, Cost Plus Drugs co-founder
Succeeding as an Insecure Overachiever
Professor Laura Empson pulls back the curtain on insecure overachieving professionals and explains how they can come to accept damaging patterns of overwork as inevitable and even desirable
Negotiation: Splitting the Pie
Professor Barry Nalebuff of the Yale School of Management explains what is really at stake in any negotiation and ensures you get your half
A Harvard Dean’s Blueprint for Fortune 500 C-Suites to Magnify Their Growth Opportunities
Dr. Frank Doyle, Dean of the Paulson School of Engineering and Applied Sciences at Harvard University, outlines his recommendations for Fortune 500 c-suites as they strive to attract, develop, and retain the best talent for their upcoming 2023 strategic plans.
The Role of Fearless Organizations in Global Crises
Harvard Business School Professor Amy C. Edmondson talks about achieving psychological safety in the workplace.
M&A: Three Guiding Principles of Execution Excellence
Harvard Business School’s Robert S. Kaplan, co-inventor of the Balanced Scorecard offers three guiding principles of M&A execution excellence.
485 Route 1 South,Building F, Suite 210Iselin, NJ 08830